Skip to main content
Clinical Trials/NCT04013061
NCT04013061
Completed
Not Applicable

Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery

Centre Hospitalier Universitaire de Nīmes3 sites in 1 country378 target enrollmentFebruary 25, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgical Procedures, Operative
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
378
Locations
3
Primary Endpoint
Rate of patients with at least one medication error for chronic treatment
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery

Registry
clinicaltrials.gov
Start Date
February 25, 2020
End Date
September 30, 2021
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient has at least one chronic medication prescription (associated with a chronic illness)
  • The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse

Exclusion Criteria

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is having ambulatory programmed surgery
  • The patient has an anesthetic consultation in a different health establishment

Outcomes

Primary Outcomes

Rate of patients with at least one medication error for chronic treatment

Time Frame: 48 hours post-admission

%

Secondary Outcomes

  • Nature of medication error(48 hours post-admission)
  • Rate of medication errors corrected(48 hours post-admission)
  • Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations(48 hours post-admission)
  • Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018(48 hours post-admission)
  • Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery(48 hours post-admission)
  • Rate of medications not available on the establishment's therapeutic book and not brought by the patient(48 hours post-admission)
  • Duration in hospital(End of hospitalization (max 30 days))
  • Rate of delay or cancellation of surgery linked to preoperational medication error(End of study (13 months))

Study Sites (3)

Loading locations...

Similar Trials